Olmesartan Medoxomil 20mg Tablet

Adult dose

The recommended initial dose is 10mg once daily, taken regardless of meals. If blood pressure is not adequately controlled at this dosage, it may be increased to 20mg once daily, with a maximum increase to 40mg once daily. The antihypertensive effect appears within 2 weeks after starting therapy, with maximum effect observed around 8 weeks. If blood pressure is not controlled, it may be administered in combination with thiazide diuretics. Older adults (aged 65 or above)

Child dose

Safety and efficacy in pediatric patients have not been established.

This medication can cause serious harm to the fetus and newborn if administered to women in the second and third trimesters of pregnancy, thus it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to any components of this drug, women who are pregnant or breastfeeding, patients undergoing renal dialysis, those with severe liver dysfunction, patients with biliary obstruction, and those with certain genetic lactose intolerance disorders. In patients with low blood volume or sodium deficiency, low blood pressure may occur; therefore, conditions must be thoroughly assessed before administration, and appropriate measures should be taken if hypotension occurs. This drug may affect kidney function, so patients with impaired renal function should regularly undergo blood tests to monitor kidney status and potassium levels. There is a risk of hyperkalemia, so patients with heart disease or renal disease should regularly monitor potassium levels in the blood. Dizziness may occur due to the blood pressure lowering effect, so caution should be exercised when performing hazardous tasks such as working at heights or driving. During the use of this medication, drug interactions may occur if combined with other antihypertensives, potassium-sparing diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, etc., thus it is essential to consult with healthcare professionals. If gastrointestinal symptoms such as chronic diarrhea or weight loss occur, discontinue use of this medication and consult a physician, and if symptoms of intestinal vascular edema are observed, treatment should be discontinued immediately and further observation is required. Pregnant or breastfeeding women should consult with a physician before taking this medication, and if breastfeeding, consideration should be given to discontinuing the medication or breastfeeding during treatment. Safety in children has not been fully established, so it should be administered with caution in pediatric patients. In case of overdose, symptoms such as hypotension or palpitations may occur; therefore, it is crucial to adhere to the prescribed dosage and notify healthcare providers immediately if any adverse symptoms arise.

Serious side effects

Urticaria, angioedema, anaphylactic reaction, hyperkalemia, acute renal failure, elevated serum creatinine, urticaria, angioedema, liver dysfunction (increased transaminases or total bilirubin), severe allergic reactions, severe skin adverse reactions, breathing difficulties, severe edema or urination abnormalities, serious neurological symptoms

Mild side effects

• Dizziness
• headache
• palpitations
• abdominal pain
• dyspepsia
• gastroenteritis
• nausea
• low back pain
• bronchitis
• increased creatine kinase

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature in the range of 1 to 25 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer time.

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle